Found: 52
Select item for more details and to access through your institution.
Abacavir Drug Exposures in African Children Under 14 kg Using Pediatric Solid Fixed Dose Combinations According to World Health Organization Weight Bands.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 11, p. 574, doi. 10.1093/jpids/piad082
- By:
- Publication type:
- Article
ANALYSIS OF ABACAVIR LAMIVUDINE AND ZIDOVUDINE BY SPECTROPHOTOMETRIC METHOD IN TRIPLE MIXTURE.
- Published in:
- Journal of Faculty of Pharmacy of Ankara University / Ankara Üniversitesi Eczacilik Fakültesi Dergisi, 2023, v. 47, n. 3, p. 927, doi. 10.33483/jfpau.1329821
- By:
- Publication type:
- Article
Epstein-Barr virus encephalitis presenting with brain mass lesions in a patient with human immunodeficiency virus infection.
- Published in:
- HIV & AIDS Review. International Journal of HIV-Related Problems, 2023, v. 22, n. 3, p. 274, doi. 10.5114/hivar.2023.131632
- By:
- Publication type:
- Article
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
- Published in:
- HIV Medicine, 2022, v. 23, n. 8, p. 849, doi. 10.1111/hiv.13268
- By:
- Publication type:
- Article
Bone mineral density, kidney function and participant‐reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir.
- Published in:
- HIV Medicine, 2022, v. 23, n. 4, p. 362, doi. 10.1111/hiv.13215
- By:
- Publication type:
- Article
Bone mineral density, kidney function, weight gain and insulin resistance in women who switch from TDF/FTC/NNRTI to ABC/3TC/DTG.
- Published in:
- HIV Medicine, 2021, v. 22, n. 2, p. 83, doi. 10.1111/hiv.12961
- By:
- Publication type:
- Article
Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults.
- Published in:
- AIDS Research & Therapy, 2020, v. 17, n. 1, p. 1, doi. 10.1186/s12981-020-00272-5
- By:
- Publication type:
- Article
Once-daily Doravirine for Initial Treatment of Adults Living With Human Immunodeficiency Virus–1: An Integrated Safety Analysis.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 7, p. 1336, doi. 10.1093/cid/ciz423
- By:
- Publication type:
- Article
Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks.
- Published in:
- BMC Pharmacology & Toxicology, 2018, v. 19, n. 1, p. N.PAG, doi. 10.1186/s40360-018-0252-z
- By:
- Publication type:
- Article
Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Too much A<sub>2</sub> -- but does the patient really have beta thalassemia trait?
- Published in:
- Medical Laboratory Observer (MLO), 2018, v. 50, n. 2, p. 14
- By:
- Publication type:
- Article
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 12, p. 2112, doi. 10.1093/cid/cix734
- By:
- Publication type:
- Article
Dolutegravir plus abacavir/lamivudine works in adolescents, but size matters.
- Published in:
- 2017
- By:
- Publication type:
- letter
Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/9324310
- By:
- Publication type:
- Article
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.
- Published in:
- HIV Medicine, 2017, v. 18, n. 7, p. 482, doi. 10.1111/hiv.12479
- By:
- Publication type:
- Article
Ready for HIV Dual Therapy? - New Data from IAS 2017.
- Published in:
- AIDS Reviews, 2017, v. 19, n. 3, p. 175, doi. 10.24875/AIDSRev.M17000009
- By:
- Publication type:
- Article
Abacavir/Dolutegravir/Lamivudine (Triumeq)-Induced Liver Toxicity in a Human Immunodeficiency Virus- Infected Patient.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 3, p. 1, doi. 10.1093/ofid/ofx122
- By:
- Publication type:
- Article
Integrase strand transfer inhibitor-associated diabetes mellitus: A case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Zidovudina/Lamivudina vs Abacavir/Lamivudina vs Tenofovir/Emtricitabina en combinaciones de dosis fija como tratamiento inicial en pacientes con VIH: revisión sistemática y metanálisis en red.
- Published in:
- Colombia Medica, 2017, v. 48, n. 2, p. 70
- By:
- Publication type:
- Article
Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks.
- Published in:
- HIV/AIDS - Research & Palliative Care, 2017, v. 9, p. 51, doi. 10.2147/HIV.S108756
- By:
- Publication type:
- Article
A severe hypersensitivity reaction to abacavir following re-challenge.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2016, v. 35, n. 5, p. 815, doi. 10.1007/s10096-016-2602-3
- By:
- Publication type:
- Article
Comparative risk of failure of ABC/3 TC or TDF/ FTC based first-line regimens in patients with a high viral load.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 380, doi. 10.1111/hiv.12306
- By:
- Publication type:
- Article
The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir.
- Published in:
- HIV Medicine, 2016, v. 17, n. 2, p. 106, doi. 10.1111/hiv.12281
- By:
- Publication type:
- Article
Dolutegravir-induced colitis in an HIV-infected patient.
- Published in:
- 2016
- By:
- Publication type:
- case study
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 12, p. 3323, doi. 10.1093/jac/dkv276
- By:
- Publication type:
- Article
Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
- Published in:
- HIV Medicine, 2015, v. 16, n. 6, p. 388, doi. 10.1111/hiv.12243
- By:
- Publication type:
- Article
Combination dolutegravir-abacavir-lamivudine in the management of HIV/AIDS: clinical utility and patient considerations.
- Published in:
- Patient Preference & Adherence, 2015, v. 9, p. 299, doi. 10.2147/PPA.S65199
- By:
- Publication type:
- Article
A Randomized Comparative Trial of Continued Abacavir/Lamivudine plus Efavirenz or Replacement with Efavirenz/Emtricitabine/Tenofovir DF in Hypercholesterolemic HIV-1 Infected Individuals.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0116297
- By:
- Publication type:
- Article
Virological efficacy of abacavir: systematic review and meta-analysis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 12, p. 3169, doi. 10.1093/jac/dku279
- By:
- Publication type:
- Article
Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 12, p. 3356, doi. 10.1093/jac/dku265
- By:
- Publication type:
- Article
Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19605
- By:
- Publication type:
- Article
Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naïve patients.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19773
- By:
- Publication type:
- Article
ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1–Infected, Antiretroviral Therapy–Naive Subjects.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 7, p. 1032
- By:
- Publication type:
- Article
Correction: Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0103925
- Publication type:
- Article
Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096187
- By:
- Publication type:
- Article
Hip Structural Parameters over 96 Weeks in HIV-Infected Adults Switching Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094858
- By:
- Publication type:
- Article
HLA Alleles Association with Changes in Bone Mineral Density in HIV-1-Infected Adults Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0093333
- By:
- Publication type:
- Article
Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 4, p. 555
- By:
- Publication type:
- Article
Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 2, p. 189, doi. 10.1002/jcph.181
- By:
- Publication type:
- Article
Neutrophil gelatinase-associated lipocalin, a marker of tubular dysfunction, is not increased in long-term virologically controlled patients receiving a tenofovir/emtricitabine + nevirapine regimen.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 12, p. 2866, doi. 10.1093/jac/dkt265
- By:
- Publication type:
- Article
Changes in Fat Mitochondrial DNA and Function in Subjects Randomized to Abacavir-Lamivudine or Tenofovir DF–Emtricitabine With Atazanavir-Ritonavir or Efavirenz: AIDS Clinical Trials Group Study A5224s, Substudy of A5202.
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 4, p. 604, doi. 10.1093/infdis/jis720
- By:
- Publication type:
- Article
Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicenter cohort of HIV-infected ARV-experienced patients.
- Published in:
- Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18343
- By:
- Publication type:
- Article
Current options in the management of opioid dependence: A review.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2011, v. 24, n. 5, p. 41, doi. 10.1097/01720610-201105000-00007
- By:
- Publication type:
- Article
Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P42, doi. 10.1186/1758-2652-13-S4-P42
- By:
- Publication type:
- Article
Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P80, doi. 10.1186/1758-2652-13-S4-P80
- By:
- Publication type:
- Article
Tolerance and durability of abacavir/lamivudine (ABC/3TC)-containing regimens: results from a large prospective French cohort.
- Published in:
- 2010
- By:
- Publication type:
- Abstract